This Title All WIREs
How to cite this WIREs title:
WIREs Nanomed Nanobiotechnol
Impact Factor: 9.182

Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials

Full article on Wiley Online Library:   HTML PDF

Can't access this content? Tell your librarian.

Nanomedicine is a relatively new field that is rapidly evolving. Formulation of drugs on the nanoscale imparts many physical and biological advantages. Such advantages can in turn translate into improved therapeutic efficacy and reduced toxicity. While approximately 50 nanotherapeutics have already entered clinical practice, a greater number of drugs are undergoing clinical investigation for a variety of indications. This review aims to examine all the nanoformulations that are currently undergoing clinical investigation and their outlook for ultimate clinical translation. WIREs Nanomed Nanobiotechnol 2017, 9:e1416. doi: 10.1002/wnan.1416 This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies

Related Articles

Polymer nanoparticles for drug and small silencing RNA delivery to treat cancers of different phenotypes
Advances in the synthesis and application of nanoparticles for drug delivery
Challenges in preclinical to clinical translation for anticancer carrier‐mediated agents
Top Ten WNAN Articles

Browse by Topic

Therapeutic Approaches and Drug Discovery > Emerging Technologies

Access to this WIREs title is by subscription only.

Recommend to Your
Librarian Now!

The latest WIREs articles in your inbox

Sign Up for Article Alerts